A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer

Clinical trial NCT00558545 · TERMINATED

Trial details

NCT number: NCT00558545
Sponsor: Aegera Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Mammary Carcinoma

Start date: 2007-11-01
Primary completion: 2009-05-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.